52WeekLowStock.com, provider of Winning 52 Week Low Stock Bounce Stock Alerts, and Breakout Stock Plays, offers a newsletter to investors looking for the best stocks daily announces NASDAQ, AMEX, NYSE, OTCBB Stocks Hitting New 52 Week Lows To Play For A Bounce.
Beverly Hills, CA -- (SBWIRE) -- 10/22/2012 -- http://52WeekLowStock.com provides subscribers with a free newsletter that reports up to the minute information and exclusive charts on cheap, undervalued, hidden, and undiscovered stocks making new lows in the United States that can bounce.
The Dow and S&P 500 edged lower in choppy trading Monday, extending losses after major averages logged their worst one-day decline since June, following some mixed quarterly results that highlighted the impact of slower global growth on corporate revenues.
NxStage Medical, Inc. (NxStage) is a medical device company that develops, manufactures and markets products for the treatment of kidney failure, fluid overload and related blood treatments and procedures. The Company’s primary product is the NxStage System One (System One). It also sells needles and blood tubing sets primarily to dialysis clinics for the treatment of end-stage renal disease (ESRD). It operates in two segments: System One and In-Center. It distributes its products in three markets: home, critical care and in-center. In the System One segment it derives its revenues from the sale and rental of the System One and PureFlow SL equipment, and the sale of disposable products in the home and critical care markets. In the In-Center segment, it derives its revenues from the sale of blood tubing sets and needles for hemodialysis primarily for the treatment of ESRD patients at dialysis centers and needles for apheresis, which is referred to as the in-center market. The Stock hit a new low of $11.58 on Monday
DISCOVER STOCKS READY TO BOUNCE
52Weeklowstock.com is working on its next Undiscovered Company Special Report. These Special Reports typically see fast gains. Reports are issued to members only, Goto http://52weeklowstock.com to subscribe for free.
Disclosure: 52 Week Low Stock is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. This press release may contain several forward looking statements. Please read our report and visit our website for complete risks and disclosures.
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)